Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abuse potential of mirogabalin in recreational polydrug users.
Mendell J, Levy-Cooperman N, Sellers E, Vince B, Kelsh D, Lee J, Warren V, Zahir H. Mendell J, et al. Among authors: levy cooperman n. Ther Adv Drug Saf. 2019 Apr 5;10:2042098619836032. doi: 10.1177/2042098619836032. eCollection 2019. Ther Adv Drug Saf. 2019. PMID: 31057786 Free PMC article.
Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial.
Walsh SL, Comer SD, Lofwall MR, Vince B, Levy-Cooperman N, Kelsh D, Coe MA, Jones JD, Nuzzo PA, Tiberg F, Sheldon B, Kim S. Walsh SL, et al. Among authors: levy cooperman n. JAMA Psychiatry. 2017 Sep 1;74(9):894-902. doi: 10.1001/jamapsychiatry.2017.1874. JAMA Psychiatry. 2017. PMID: 28655025 Free PMC article. Clinical Trial.
Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist.
Levy-Cooperman N, McIntyre G, Bonifacio L, McDonnell M, Davenport JM, Covington PS, Dove LS, Sellers EM. Levy-Cooperman N, et al. J Pharmacol Exp Ther. 2016 Dec;359(3):471-481. doi: 10.1124/jpet.116.236547. Epub 2016 Sep 19. J Pharmacol Exp Ther. 2016. PMID: 27647873 Free PMC article. Clinical Trial.
Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.
Schoedel KA, Sun H, Sellers EM, Faulknor J, Levy-Cooperman N, Li X, Kennedy WP, Cha JH, Lewis NM, Liu W, Bondiskey P, McCrea JB, Panebianco DL, Troyer MD, Wagner JA. Schoedel KA, et al. J Clin Psychopharmacol. 2016 Aug;36(4):314-23. doi: 10.1097/JCP.0000000000000516. J Clin Psychopharmacol. 2016. PMID: 27253658 Clinical Trial.
Oral Human Abuse Potential of Oxycodone DETERx® (Xtampza® ER).
Kopecky EA, Fleming AB, Levy-Cooperman N, O'Connor M, M Sellers E. Kopecky EA, et al. Among authors: levy cooperman n. J Clin Pharmacol. 2017 Apr;57(4):500-512. doi: 10.1002/jcph.833. Epub 2016 Nov 1. J Clin Pharmacol. 2017. PMID: 27669664 Free PMC article. Clinical Trial.
27 results